Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Market Cap	12.27B
Revenue (ttm)	9.30B
Net Income (ttm)	1.26B
Shares Out	168.76M
EPS (ttm)	7.45
PE Ratio	9.76
Forward PE	9.58
Dividend	1.50 (2.06%)
Ex-Dividend Date	Apr 22, 2025

Volume	115,727
Average Volume	371,626
Open	72.72
Previous Close	72.72
Day's Range	72.39 - 73.70
52-Week Range	43.50 - 83.99
Beta	0.53
RSI	50.36
Earnings Date	Mar 2, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.